Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 228.5% in October

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 56,500 shares, an increase of 228.5% from the September 30th total of 17,200 shares. Based on an average daily trading volume, of 58,800 shares, the short-interest ratio is currently 1.0 days.

Fresenius SE & Co. KGaA Price Performance

Shares of FSNUY stock traded down $0.03 during trading hours on Friday, reaching $9.11. The company had a trading volume of 25,057 shares, compared to its average volume of 27,428. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.00 and a current ratio of 1.29. The stock has a fifty day moving average of $9.28 and a 200-day moving average of $8.38. The company has a market capitalization of $20.34 billion, a price-to-earnings ratio of 12.24 and a beta of 1.05. Fresenius SE & Co. KGaA has a 12-month low of $6.33 and a 12-month high of $9.78.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.22 EPS for the quarter. The firm had revenue of $5.83 billion for the quarter. On average, equities analysts anticipate that Fresenius SE & Co. KGaA will post 0.84 earnings per share for the current year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.